Cetera Advisor Networks LLC Purchases 35,528 Shares of iShares NASDAQ Biotechnology Index (IBB)

Cetera Advisor Networks LLC raised its position in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 196.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,640 shares of the financial services provider’s stock after purchasing an additional 35,528 shares during the period. Cetera Advisor Networks LLC owned 0.06% of iShares NASDAQ Biotechnology Index worth $5,734,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Crestwood Advisors Group LLC raised its stake in shares of iShares NASDAQ Biotechnology Index by 1.6% during the 3rd quarter. Crestwood Advisors Group LLC now owns 69,893 shares of the financial services provider’s stock worth $23,316,000 after purchasing an additional 1,107 shares in the last quarter. Atlantic Trust Group LLC raised its stake in shares of iShares NASDAQ Biotechnology Index by 12.4% during the 3rd quarter. Atlantic Trust Group LLC now owns 20,642 shares of the financial services provider’s stock worth $6,887,000 after purchasing an additional 2,280 shares in the last quarter. Mathes Company Inc. raised its stake in shares of iShares NASDAQ Biotechnology Index by 190.4% during the 4th quarter. Mathes Company Inc. now owns 13,605 shares of the financial services provider’s stock worth $1,453,000 after purchasing an additional 8,920 shares in the last quarter. Burns J W & Co. Inc. NY raised its stake in shares of iShares NASDAQ Biotechnology Index by 187.2% during the 4th quarter. Burns J W & Co. Inc. NY now owns 27,073 shares of the financial services provider’s stock worth $2,891,000 after purchasing an additional 17,647 shares in the last quarter. Finally, Stephens Inc. AR raised its stake in shares of iShares NASDAQ Biotechnology Index by 231.5% during the 4th quarter. Stephens Inc. AR now owns 13,298 shares of the financial services provider’s stock worth $1,420,000 after purchasing an additional 9,286 shares in the last quarter. 27.28% of the stock is owned by institutional investors.

iShares NASDAQ Biotechnology Index (NASDAQ IBB) opened at $107.54 on Wednesday. iShares NASDAQ Biotechnology Index has a one year low of $94.20 and a one year high of $119.30. The firm has a market capitalization of $9,460.00, a P/E ratio of 3.55 and a beta of 1.37.

COPYRIGHT VIOLATION NOTICE: “Cetera Advisor Networks LLC Purchases 35,528 Shares of iShares NASDAQ Biotechnology Index (IBB)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/cetera-advisor-networks-llc-purchases-35528-shares-of-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply